Pharvaris (PHVS) Restructuring Costs (2021 - 2024)
Pharvaris (PHVS) reported Restructuring Costs of $147173.4 for Q4 2024, up 1037.92% on a YoY basis from $12933.6 in Q1 2024, and up 1037.92% quarter-over-quarter from -$15691.5 in Q4 2023.
Pharvaris (PHVS) Restructuring Costs (2021 - 2024) Analysis & Trends
Pharvaris has reported Restructuring Costs for 4 years, with the latest figure at $147173.4 in Q4 2024.
- For the quarter ending Q4 2024, Restructuring Costs rose 1037.92% year-over-year to $147173.4; the trailing twelve-month figure through Dec 2024 stood at $147173.4 (up 1037.92% YoY), and the FY2024 full-year result was $149066.1, up 1044.91% from the prior year.
- Restructuring Costs for Q4 2024 stood at $147173.4, up from -$15691.5 in the prior quarter.
- The five-year high for Restructuring Costs was $147173.4 in Q4 2024, with the low at -$261755.4 in Q4 2021.
- Historically, Restructuring Costs has averaged -$49045.6 across 4 years, with a median of -$15691.5 in 2023.
- Annual changes were most pronounced in 2022 — Restructuring Costs soared 55.72% — and 2024, when it jumped 1037.92%.
- Pharvaris' Restructuring Costs stood at -$261755.4 in 2021, then surged by 55.72% to -$115903.2 in 2022, then soared by 86.46% to -$15691.5 in 2023, then soared by 1037.92% to $147173.4 in 2024.
- The last three Restructuring Costs figures came in at $147173.4 (Q4 2024), -$15691.5 (Q4 2023), and -$115903.2 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Pharvaris | 28.66 Bn | 28.37 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 147,173.37 |
| Dec 31, 2023 | -15,691.51 |
| Dec 31, 2022 | -115,903.16 |
| Sep 30, 2022 | 948.79 |
| Dec 31, 2021 | -261,755.43 |